Amlodipine ankle oedema — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Arrange prescriber review for dose reduction or switch after checking red flags
Dihydropyridine calcium-channel blockers commonly cause dose-related peripheral oedema. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.
Reference: BNF; NICE CKS